Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

  • May 22, 2026

Recorded at Fierce Biotech Week in Boston, this episode of “The Top Line” features a conversation with BioAge co-founder and CEO Kristen Fortney on aging biology, inflammation and why BioAge believes its oral NLRP3 inhibitor could have applications across multiple diseases.

Leave A Comment

Fields (*) Mark are Required